What the CA 15-3 test shows
CA 15-3 (cancer antigen 15-3) measures a fragment of MUC1, a large protein that normally coats the surface of glandular cells, including those in the breast. Breast tumors — especially larger or spreading ones — shed extra MUC1 into the blood, so the level roughly tracks how much active breast-cancer tissue is present. It does not cause cancer but is shed by the tumor, as the National Cancer Institute explains.
Its role is narrow and often misunderstood. CA 15-3 is a monitoring marker, not a screening or diagnostic one. It is used mainly to follow known, advanced (metastatic) breast cancer during treatment — a falling level suggests the cancer is shrinking, a rising trend that it may be growing — as MedlinePlus describes.
It differs from its close relatives. CEA is a more general tumor marker often measured alongside it in breast cancer, because the pair together catch more recurrences than either alone. CA 27-29 is a separate test for the same MUC1 antigen; it overlaps in purpose but not in numbers. Because assays target different parts of the molecule, CA 15-3 results from different labs or kits are not interchangeable.
CA 15-3 normal range
CA 15-3 is reported in U/mL, numerically the same as the SI unit kU/L. It is read less as “in range versus out of range” and more as a trend plus a set of interpretation bands. Typical adult orientation:
| CA 15-3 level (U/mL = kU/L) | What it usually suggests |
|---|---|
| Below ~30 | Reference range for healthy adults |
| ~30–50 | Mild elevation — often benign; possibly early or low-burden cancer |
| Above ~50 | Clearer elevation — in known cancer, points to larger or metastatic disease |
| A rising trend over months | More meaningful than any single value during monitoring |
The number does not differ meaningfully between men and women, and there is no useful “low” threshold — lower is simply better. It rises slightly in normal pregnancy and breastfeeding. The cutoff itself is assay-dependent (many labs use <30 U/mL; some <25 or ~31), and values are not interchangeable between methods, so read your result against your own lab’s range and, ideally, against your own previous results.
Why CA 15-3 is high
A raised CA 15-3 has a long list of causes, and most mild elevations are not cancer. Roughly by how often they explain a high result:
- Benign conditions. Liver disease is the classic one — the liver clears CA 15-3, so cirrhosis, hepatitis and cholestasis push it up. Benign breast disease, benign ovarian cysts, endometriosis, and normal pregnancy or breastfeeding also raise it modestly, as does chronic inflammation.
- Advanced breast cancer. This is the elevation the test is built to follow. Levels are highest in metastatic disease, particularly with spread to the liver or bones. Importantly, fewer than half of early, localized breast cancers raise CA 15-3 at all — so a normal value never rules cancer out, per the NCI.
- Other cancers. Ovarian, lung, pancreatic and colorectal cancers can raise MUC1 too, which is part of why the marker is too non-specific to screen with.
When is it urgent? A single mildly raised value in someone without known cancer is rarely an emergency, but it should be discussed with a doctor rather than ignored. In someone already treated for breast cancer, a genuine rising trend — confirmed on a repeat test — warrants prompt imaging to check for recurrence.
Why CA 15-3 is low
For a tumor marker, low is the goal, not a problem. No disease makes CA 15-3 “too low,” and you cannot be deficient in it. A low or normal result during and after breast-cancer treatment is the reassuring outcome clinicians look for: it is consistent with a cancer that is responding, shrinking or in remission.
The catch is what a normal value does not tell you. Because CA 15-3 is elevated in fewer than half of early breast cancers, and some tumors never produce it, a normal result cannot be used to prove there is no cancer, in line with ASCO’s biomarker guidance. Detection still rests on examination, mammography and other imaging — not on a reassuring marker.
What to test alongside
CA 15-3 is never interpreted on its own. The markers ordered around it fall into three groups:
- CEA — the general tumor marker most often paired with CA 15-3 in breast cancer, since the two together detect more recurrences than either by itself.
- Organ-specific tumor markers, which is why breast uses CA 15-3 while other sites use their own: CA 125 and HE4 for ovarian cancer, CA 19-9 for pancreatic and biliary cancer, AFP for liver and germ-cell tumors, and PSA for the prostate.
- ALT and AST — liver enzymes, because liver disease is a common benign reason for a raised CA 15-3 and liver metastases are a common malignant one.
The tests that actually detect breast cancer are not blood markers at all but imaging (mammography, ultrasound, MRI) and biopsy with receptor testing (estrogen, progesterone, HER2).
What to do about an abnormal result
- Don’t panic over one number. An isolated mildly raised CA 15-3 is far more often benign — liver, breast or inflammatory — than cancer, and the test is not designed to diagnose disease.
- Repeat and trend. A single value means little; an abnormal result is rechecked, and the direction over weeks to months is what counts.
- Give the lab context. Pregnancy, breastfeeding, liver disease and the assay used all shift the number, so results are read against your own earlier ones from the same lab.
- See the right doctor. With no cancer diagnosis, your primary-care physician coordinates the work-up and decides whether anything further is needed. If you are being treated for breast cancer, your oncologist reads the marker alongside your imaging and symptoms.
- Never use it to self-clear or self-diagnose. A normal CA 15-3 does not rule cancer out, and a high one does not rule it in — only your care team, with imaging and examination, can put the number in context.
Mini-FAQ
Can a CA 15-3 test diagnose breast cancer?
No. It is not a screening or diagnostic test, and major guidelines (ASCO, NCCN, ESMO) advise against using it to detect or rule out breast cancer. It is used mainly to monitor known, advanced disease during treatment.
What is a normal CA 15-3 level?
Most labs use below about 30 U/mL (numerically the same as kU/L), though the exact cutoff depends on the assay. Results from different labs or kits cannot be compared directly, so read your value against your own report.
Does a normal CA 15-3 mean I don’t have breast cancer?
No. Fewer than half of early, localized breast cancers raise CA 15-3, and some tumors never produce it, so a normal value cannot rule cancer out. Detection relies on examination and imaging, not on this marker.
What can raise CA 15-3 apart from breast cancer?
Benign conditions such as liver disease, benign breast or ovarian disease, endometriosis, pregnancy and breastfeeding can all raise it, as can other cancers (ovarian, lung, pancreatic, colorectal). That is why one high value is not proof of cancer.
How is CA 15-3 used during breast cancer treatment?
In advanced (metastatic) disease it is tracked as an adjunct: a falling level suggests the cancer is responding, a rising trend can signal progression. It is interpreted alongside imaging and symptoms, never alone, and the trend over time matters more than any single reading.
